ImmuneSpec is your trusted partner for immunopeptidomics (MAPPs). We provide the most high-sensitive immunopeptidomics analysis ensuring maximized peptide identifications and unmatched sensitivity. Our client-focused approach guarantees high-quality results, seamless collaboration, rapid turnaround, and scientifically rigorous results tailored to your research needs.
WHY CHOOSE US
Your Trusted Partner for Precision Immunopeptidomics Solutions
Our vision is to set a new standard in healthcare by harnessing our advanced immunopeptidomics platform, enabling the optimization and personalization of biotherapeutics, and ultimately improving patient outcomes across a wide range of medical conditions
ADVANCED APPLICATIONS
Driving discovery and
development in Biotherapeutics
Use MHC associated peptide proteomics (MAPPs) to decipher all T cell epitopes of a biotherapeutic for immunogenicity risk assessment.
MAPPs is the most accurate and reliable assay to assess immunogenicity risk of your biotherapeutics.
Ranking or selection of safe, high efficacy biotherapeutics during early preclinical phases.
DISCOVER OUR
Newsroom
Stay informed and ahead of the curve with our latest news and insightful whitepapers. We cover industry trends, innovations, and expert perspectives to keep you updated on all the crucial developments. Whether you’re looking for quick updates or in-depth analysis, our content is designed to provide valuable knowledge. Visit our News & Whitepapers section to explore more and stay up to date with the latest insights.
